NEW YORK (Reuters Health)—Brain connectivity differences predict placebo responses in patients with chronic knee osteoarthritis, researchers report. Positive medical responses to placebo treatments are common, but the underlying central nervous system mechanisms remain unclear. Dr. Marwan N. Baliki and colleagues from the Feinberg School of Medicine at Northwestern University in Chicago used resting-state functional MRI…
Search results for: chronic pain
Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use
NEW YORK (Reuters Health)—Medical cannabis reduces chronic pain patients’ opioid use, while improving their quality of life, according to a new survey of Michigan cannabis dispensary patrons. “They report that when they make that switch they overall feel better,” Dr. Daniel J. Clauw of the University of Michigan, Ann Arbor, told Reuters Health in a…
Chronic Pain: The Psychiatric Perspective
Why rheumatic pain is more than a joint issue
Pediatric Chronic Pain Eased by Early Intervention, Parental Involvement
Comfort Ability program provides psychological strategies to help children self-manage symptoms
Closer Scrutiny of Chronic Pain Patients Needed
A new study links high costs to patients with chronic pain conditions and an opioid prescription.
Couples Coping with Chronic Pain
Spouses provide help to their partners, but also need help themselves
Self-Administered Acupressure Promising for Chronic Back Pain Relief
Researchers examined the benefits of two acupressure approaches for treating low back pain, finding that patients who self-administered stimulating acupressure experienced a significant decrease in fatigue associated with their chronic pain…
FDA Considers Tanezumab Application for Chronic OA Pain
The FDA is considering an application for subcutaneous tanezumab, a monoclonal antibody, as a treatment for moderate to severe osteoarthritis…
From Chronic Low Back Pain to Axial Spondyloarthritis
ATLANTA—Research into possible genetic drivers of the axial spondyloarthritis (axSpA), including the role of the genetic marker HLA-B27, is advancing, John D. Reveille, MD, professor and vice chair of medicine at the University of Texas McGovern Medical School, Houston, told attendees at the 2019 ACR/ARP Annual Meeting. Dr. Reveille delivered the Philip Hench, MD, Memorial…
Antidepressant of No Clear Value in Chronic Low-Back Pain
NEW YORK (Reuters Health)—Low-dose amitriptyline does not have clear benefits for patients with chronic low-back pain that has no specific cause, according to results from a randomized clinical trial. Despite the lack of evidence that antidepressants are more effective than placebo for low-back pain, seven of 14 national and international guidelines recommend their use in…